Bioventus, Inc. (BVS)
8.97
-0.18
(-1.97%)
USD |
NASDAQ |
Apr 02, 16:00
8.955
-0.02
(-0.17%)
After-Hours: 20:00
Bioventus EPS Diluted (Quarterly) : 0.213 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.32M |
| Revenue (Quarterly) | 157.90M |
| Total Expenses (Quarterly) | 143.14M |
| Enterprise Value | 908.74M |
| Gross Profit Margin (Quarterly) | 68.07% |
| Profit Margin (Quarterly) | 10.97% |
| Earnings Yield | 3.73% |
| Operating Earnings Yield | 9.59% |
| Normalized Earnings Yield | 4.146 |